Ardent Health CFO buys 10,000 shares

Ardent Health, Inc. Chief Financial Officer Alfred Lumsdaine made an open-market purchase of 10,000 shares of Common Stock at $8.81 per share.

Rhea-AI Filing Summary

Ardent Health, Inc. Chief Financial Officer Alfred Lumsdaine made an open-market purchase of 10,000 shares of Common Stock at $8.81 per share. After this transaction, he directly owns 329,183 shares, increasing his personal stake in the company.

Insights

Equity ownership analyst

Ardent Health’s CFO modestly increases his direct shareholding through an open-market purchase.

The filing shows CFO Alfred Lumsdaine executed an open-market purchase of 10,000 shares of Ardent Health Common Stock at $8.81 per share. This is a straightforward, non-derivative transaction classified as an open-market purchase.

Following the trade, his direct holdings rise to 329,183 shares, with no derivative positions listed in this filing. As a single transaction without additional context on company size or total float, it appears as a routine insider buy rather than a clearly thesis-changing event.

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 1 txn

Insider LUMSDAINE ALFRED

Role Chief Financial Officer

Bought 10,000 shs ($88K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,000	$8.81	$88K

Holdings After Transaction: Common Stock — 329,183 shares (Direct)

Key Figures

Shares purchased: 10,000 shares Purchase price: $8.81 per share Shares owned after: 329,183 shares +2 more

5 metrics

Shares purchased 10,000 shares Open-market purchase of Common Stock

Purchase price $8.81 per share Price paid for Common Stock on transaction date

Shares owned after 329,183 shares Direct holdings following the transaction

Net buy shares 10,000 shares Net buy-sell shares in this Form 4

Buy transactions count 1 transaction Number of buy transactions reported

Key Terms

open-market purchase, Common Stock, non-derivative, direct ownership

4 terms

open-market purchase financial

"transaction_action: open-market purchase of Common Stock shares"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"security_title: Common Stock reported in the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type: non-derivative indicating direct share trade"

direct ownership financial

"ownership_type: direct with code D for this holding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ardent Health (ARDT) report for its CFO?

Ardent Health reported that CFO Alfred Lumsdaine bought 10,000 Common Stock shares in an open-market transaction. The shares were purchased at $8.81 each, increasing his direct ownership stake in the company.

At what price did the Ardent Health (ARDT) CFO buy shares?

The CFO purchased 10,000 Ardent Health Common Stock shares at $8.81 per share. This open-market price reflects what he paid in the reported transaction, as disclosed in the Form 4 insider filing.

How many Ardent Health (ARDT) shares does the CFO own after the transaction?

After the reported purchase, CFO Alfred Lumsdaine directly owns 329,183 Ardent Health Common Stock shares. This figure comes from the Form 4, which updates his holdings following the 10,000-share open-market buy.

Was the Ardent Health (ARDT) CFO’s transaction a buy or a sell?

The transaction was a buy. The Form 4 classifies it as an open-market purchase, with the CFO acquiring 10,000 Common Stock shares and no sales or derivative exercises reported in this filing.

Does the Ardent Health (ARDT) Form 4 show any derivative securities activity?

No derivative securities activity is shown in this Form 4. The filing reports only a non-derivative open-market purchase of Common Stock, and the derivative summary section lists no remaining derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 12:50 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUMSDAINE ALFRED

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		P		10,000	A	$8.81	329,183	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)